Akonni's $3M Grant Latest in String of NIH Awards for PCR Array-Based Infectious Disease Dxs
September 30, 2010
Akonni's $3M Grant Latest in String of NIH Awards for PCR Array-Based Infectious Disease Dxs
A company official said that Akonni's technology, which combines the power of real-time PCR interrogation with microarray analysis, is well-suited to address the emergence of drug resistance and the need to interrogate a broader range of markers in infectious disease.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Akonni Wins $435K SBIR Grant to Develop POC Tuberculosis Dx on PCR Array Technology
July 29, 2010 / PCR Insider - Product Watch: Akonni Biosystems and Sage Science
January 17, 2013 / PCR Insider - Dx Focus: Akonni TruDiagnosis Studies; Spartan Bio CYP2C19 Test; Mitomics Prostate Cancer Assay
January 10, 2013 / PCR Insider - Product Watch: Akonni TruTip and Illumina TruSeq Sample Prep Kits
September 20, 2012 / PCR Insider - Cepheid Inks First in Series of Agreements to Buy Down Price of Xpert TB Test
August 9, 2012 / PCR Insider